MINT-METFORMIN XR
As listed in the register: MINT-METFORMIN XR
1000 mg · tablet (extended-release)
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Metformin Hydrochloride
- Made by
- Mint Pharmaceuticals Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (metformin hydrochloride). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal and postprandial plasma glucose.
Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Intravenous single-dose studies in normal subjects demonstrate that metformin is excreted unchanged in the urine and does not undergo hepatic metabolism (no metabolites have been identified in humans) nor biliary excretion.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-01-01
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (metformin hydrochloride). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: LACTIC ACIDOSIS Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias.
- Metformin hydrochloride tablets are contraindicated in patients with: Severe renal impairment (eGFR below 30 mL/min/1.73 m 2 ) [see Warnings and Precautions (5.1) ].
- Hypersensitivity to metformin.
- Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.
- Severe renal impairment (eGFR below 30 mL/min/1.73 m 2 ) ( 4, 5.1 ) Hypersensitivity to metformin ( 4 ) Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States90 matching products
Bulgaria19 matching products
- Metformin PR Juta 1000 mg · prolonged - release tablets2 makers
- Brotmin 1000 mg · film - coated tablets
- Glucophage 1000 mg film coated tablets · film coated tablet
- Glucophage XR 1000 mg · prolonged - release tablets
- Insufor 1000 mg film-coated tablets · film-coated tablets
- Meglucon XR 1000 mg · prolonged - release tablets
- Metfocon 1000 mg · film - coated tablets
- Metfocon XR 1000 mg prolonged-release tablets · prolonged - release tablets
Spain12 matching products
- METFORMINA ACTIVASE 1000 mg · comprimido recubierto con película
- METFORMINA AENOVA 1000 MG · comprimido recubierto con película
- METFORMINA ALMUS PHARMA 1000 mg · comprimido recubierto con película
- METFORMINA KERN PHARMA 1000 mg · comprimido recubierto con película
- METFORMINA NORMON 1000 mg · comprimido recubierto con película
- METFORMINA PENSA PHARMA 1000 mg · comprimido recubierto con película
- METFORMINA PHARMAKERN 1000 mg · comprimido recubierto con película
- METFORMINA SANDOZ 1000 mg · comprimido recubierto con película
Netherlands11 matching products
- Metformine HCl Aurobindo 1000 mg 1000 mg · filmomhulde tablet2 makers
- Glucient SR 1000 mg 1000 mg · tablet met verlengde afgifte
- Glycofren 1000 mg bruistabletten 1000 mg · bruistablet
- Metformine HCl 1000 mg Focus 1000 mg · tablet met verlengde afgifte
- Metformine HCl 1000 mg Teva 1000 mg · filmomhulde tablet
- Metformine HCl Accord 1000 mg filmomhulde tabletten 1000 mg · filmomhulde tablet
- Metformine HCl Activase 1000 mg 1000 mg · filmomhulde tablet
- Metformine HCl CF 1000 mg 1000 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Mint Pharmaceuticals Inc |
|---|---|
| Active substance | Metformin Hydrochloride |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 1000 mg |
| Form | tablet (extended-release) |
| Classification | A10BA02 · Digestion, stomach, diabetes and nutrition |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02547317 |
| DPD drug code | 103594 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet (extended-release)2 products
- 500 mg
- 1000 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.